Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
China
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong